Detected ·

201 Therapeutics

——

201 Therapeutics secured CHF 40,000 in Venture Kick Stage II funding to advance oral small molecule therapies for hepatocellular carcinoma (liver cancer).

Website
—
Amount
—
Stage
—
Event
Funding round
Detected
2026-05-27 12:10:46 UTC
Signal ID
47619ad6-cf73-4b65-b6bc-601100a6a55d

As the API returns it

{
  "id": "47619ad6-cf73-4b65-b6bc-601100a6a55d",
  "created_at": "2026-05-27T12:10:46.799229Z",
  "company_name": "201 Therapeutics",
  "company_website_url": null,
  "company_linkedin_url": "https://www.linkedin.com/company/201-therapeutics",
  "event_type": "funding",
  "funding_amount": null,
  "funding_currency": null,
  "funding_stage": null,
  "message": "*201 Therapeutics secured CHF 40,000 in Venture Kick Stage II funding to advance oral small molecule therapies for hepatocellular carcinoma (liver cancer).*"
}

Latest rounds